BACK
|In Follow Up,Obesity

Surmount-4

This is a study of tirzepatide in participants with obesity or overweight. The main purpose is to learn more about how tirzepatide maintains body weight loss. The study has two phases: a lead-in phase in which all participants take tirzepatide and a treatment phase in which participants will either continue tirzepatide or switch to placebo. The study will last about 2 years (25 visits).

More Information

Capital Area Research LLC © Copyright 2023 All rights reserved.
875 Popular Church Rd. Suite 330 Camp Hill, PA - 717.963.8389